Darunavir en pacientes avanzados con multirresistencias. Estudios POWER, DUET y BENCHMRK

Arazo Garcés, Piedad; Omiste Sanvicente, Teresa.
Enferm. infecc. microbiol. clín. (Ed. impr.) ; 26(supl.10): 23-31, oct. 2008. graf
Artículo en Español | IBECS (España) | ID: ibc-60549

Documentos relacionados

  1. Darunavir en pacientes avanzados con multirresistencias. Estudios POWER, DUET y BENCHMRK
  2. Therapeutic Drug Monitoring of HIV Antiretroviral Drugs in Pregnancy: A Narrative Review.
  3. Drug-Drug Interactions of Glecaprevir and Pibrentasvir Coadministered With Human Immunodeficiency Virus Antiretrovirals.
  4. Eficacia de dolutegravir en pacientes experimentados: estudios SAILING y VIKING
  5. Plasma trough concentrations of antiretrovirals in HIV-infected persons treated with direct-acting antiviral agents for hepatitis C in the real world.
  6. Physiologically-based pharmacokinetic modeling of renally excreted antiretroviral drugs in pregnant women.
  7. Mecanismo de acción, farmacología e interacciones de dolutegravir
  8. Drug-Drug Interactions Between Antiretrovirals and Carbamazepine/Oxcarbazepine: A Real-Life Investigation.
  9. Pharmacokinetics and tolerability of cabotegravir and rilpivirine long-acting intramuscular injections to the <i>vastus lateralis</i> (lateral thigh) muscles of healthy adult participants.
  10. Investigation of Pharmacokinetic Interactions between Doravirine and Elbasvir-Grazoprevir and Ledipasvir-Sofosbuvir.